KR101329585B1 - 항균제로서 퀴놀린 유도체 - Google Patents

항균제로서 퀴놀린 유도체 Download PDF

Info

Publication number
KR101329585B1
KR101329585B1 KR1020087002107A KR20087002107A KR101329585B1 KR 101329585 B1 KR101329585 B1 KR 101329585B1 KR 1020087002107 A KR1020087002107 A KR 1020087002107A KR 20087002107 A KR20087002107 A KR 20087002107A KR 101329585 B1 KR101329585 B1 KR 101329585B1
Authority
KR
South Korea
Prior art keywords
alkyl
compound
formula
hydrogen
alkyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020087002107A
Other languages
English (en)
Korean (ko)
Other versions
KR20080021156A (ko
Inventor
쿤라드 요제프 로데윅 마르셀 안드리스
아닐 코울
제롬 에밀리 조지 구일레몬트
데이비드 프란시스 알랭 랑코시스
마갈리 마들렌 시몬 모테
이스메트 도렌지
레오 자코브 요제프 백스
리벤 미어폴
Original Assignee
얀센 파마슈티카 엔.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34940244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101329585(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 얀센 파마슈티카 엔.브이. filed Critical 얀센 파마슈티카 엔.브이.
Publication of KR20080021156A publication Critical patent/KR20080021156A/ko
Application granted granted Critical
Publication of KR101329585B1 publication Critical patent/KR101329585B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020087002107A 2005-06-28 2006-06-26 항균제로서 퀴놀린 유도체 Expired - Fee Related KR101329585B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05105762 2005-06-28
EP05105762.8 2005-06-28
PCT/EP2006/063553 WO2007000435A1 (en) 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents

Publications (2)

Publication Number Publication Date
KR20080021156A KR20080021156A (ko) 2008-03-06
KR101329585B1 true KR101329585B1 (ko) 2013-11-15

Family

ID=34940244

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087002107A Expired - Fee Related KR101329585B1 (ko) 2005-06-28 2006-06-26 항균제로서 퀴놀린 유도체

Country Status (31)

Country Link
US (1) US8841321B2 (enExample)
EP (1) EP1898914B1 (enExample)
JP (1) JP5193858B2 (enExample)
KR (1) KR101329585B1 (enExample)
CN (1) CN101247811B (enExample)
AP (1) AP2386A (enExample)
AR (1) AR054626A1 (enExample)
AU (1) AU2006263883B2 (enExample)
BR (1) BRPI0612498A8 (enExample)
CA (1) CA2612619C (enExample)
CY (1) CY1113579T1 (enExample)
DK (1) DK1898914T3 (enExample)
EA (1) EA014423B1 (enExample)
ES (1) ES2393203T3 (enExample)
HR (1) HRP20120912T1 (enExample)
IL (1) IL188393A0 (enExample)
JO (1) JO2752B1 (enExample)
ME (1) ME01484B (enExample)
MX (1) MX2008000081A (enExample)
MY (1) MY153291A (enExample)
NO (1) NO342701B1 (enExample)
NZ (1) NZ564379A (enExample)
PA (1) PA8683801A1 (enExample)
PL (1) PL1898914T3 (enExample)
PT (1) PT1898914E (enExample)
RS (1) RS52517B (enExample)
SI (1) SI1898914T1 (enExample)
TW (1) TWI387457B (enExample)
UA (1) UA92175C2 (enExample)
WO (1) WO2007000435A1 (enExample)
ZA (1) ZA200711165B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
CN104254527B (zh) 2012-04-27 2017-05-31 詹森药业有限公司 抗菌的喹啉衍生物
AU2013254670B2 (en) 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
EP3237383B1 (en) 2014-12-23 2019-12-04 Albemarle Corporation One-step process for the synthesis of alkylated metyrapone analogs
CN106928139B (zh) * 2017-05-08 2019-06-25 福建省微生物研究所 一种贝达喹啉杂质的合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011436A1 (en) * 2002-07-25 2004-02-05 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
SI1675852T1 (sl) 2003-09-22 2009-06-30 Janssen Pharmaceutica Nv 7-amino alkilidenil-heterociklični kinoloni in naftiridoni
EP1753427B1 (en) * 2004-05-28 2008-04-02 Janssen Pharmaceutica N.V. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
DK1898909T3 (en) 2005-06-28 2017-02-06 Janssen Pharmaceutica Nv QUINOLIN DERIVATIVES AS ANTIBACTERIAL AGENTS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011436A1 (en) * 2002-07-25 2004-02-05 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Coordination Chemistry Reviews. Vol.218, pp.1-41 (2001) *
Coordination Chemistry Reviews. Vol.218, pp.1-41 (2001)*
Science, Vol.307, pp.223-227 (2005.01.14.) *
Science, Vol.307, pp.223-227 (2005.01.14.)*

Also Published As

Publication number Publication date
CY1113579T1 (el) 2016-06-22
SI1898914T1 (sl) 2013-01-31
HRP20120912T1 (hr) 2012-12-31
PA8683801A1 (es) 2007-01-17
EA014423B1 (ru) 2010-12-30
US20100048585A1 (en) 2010-02-25
BRPI0612498A8 (pt) 2018-01-02
KR20080021156A (ko) 2008-03-06
IL188393A0 (en) 2008-08-07
US8841321B2 (en) 2014-09-23
ME01484B (me) 2014-04-20
MY153291A (en) 2015-01-29
NZ564379A (en) 2010-11-26
ES2393203T3 (es) 2012-12-19
JP2008543964A (ja) 2008-12-04
AU2006263883B2 (en) 2012-12-13
TW200740437A (en) 2007-11-01
ZA200711165B (en) 2011-05-25
JP5193858B2 (ja) 2013-05-08
CA2612619C (en) 2015-12-01
AP2386A (en) 2012-03-23
RS52517B (sr) 2013-04-30
DK1898914T3 (da) 2012-11-26
MX2008000081A (es) 2008-03-24
EP1898914A1 (en) 2008-03-19
NO20080501L (no) 2008-02-28
BRPI0612498A2 (pt) 2010-11-23
PT1898914E (pt) 2012-11-20
UA92175C2 (ru) 2010-10-11
EP1898914B1 (en) 2012-08-15
CN101247811B (zh) 2013-01-02
CA2612619A1 (en) 2007-01-04
NO342701B1 (no) 2018-07-09
HK1122730A1 (en) 2009-05-29
EA200800154A1 (ru) 2008-10-30
WO2007000435A1 (en) 2007-01-04
CN101247811A (zh) 2008-08-20
AR054626A1 (es) 2007-07-04
PL1898914T3 (pl) 2013-01-31
JO2752B1 (en) 2014-03-15
TWI387457B (zh) 2013-03-01
AU2006263883A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
JP5466011B2 (ja) 抗菌性キノリン誘導体
KR101337237B1 (ko) 항균제로서의 퀴놀린 유도체
KR101514992B1 (ko) 항균성 퀴놀린 유도체
EP1901743B1 (en) Quinoline derivatives as antibacterial agents
KR101413997B1 (ko) 항균제로서의 퀴놀린 유도체
KR20090086611A (ko) 항박테리아 퀴놀린 유도체
JP5466012B2 (ja) 抗菌性キノリン誘導体
JP5356245B2 (ja) 抗菌性キノリン誘導体
KR101329585B1 (ko) 항균제로서 퀴놀린 유도체
KR101329587B1 (ko) 항균제로서의 퀴놀린 유도체
KR101413094B1 (ko) 항박테리아제로서의 퀴놀린 유도체
KR101423229B1 (ko) 항박테리아제로서의 퀴놀린 유도체
KR101318181B1 (ko) 항균제로서의 퀴놀린 유도체
HK1122730B (en) Quinoline derivatives as antibacterial agents
HK1124232B (en) Quinoline derivatives as antibacterial agents

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20161019

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20171018

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20181018

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20191016

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20211109

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20211109

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000